W.W. Grainger, Inc. · GWW · FY2026 Q3 · Calendar Q4 2026
Grainger raises FY2026 outlook again on broad Q3 growth
Grainger's Q3 performance and another increase to its full-year outlook support a constructive near-term operating picture. The durability of growth and margins remains to be tested against freight and inflation pressures, project mix, and integration costs.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about GWW FY2026 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The Q3 analysis describes double-digit organic growth across both segments and a further increase to the FY2026 outlook. It also identifies an acquisition of computer-vision and AI inventory-management technology, with an initial margin drag expected before scaling. This extends the prior quarter's raised outlook and emphasis on data-center demand and operational investment.
Guidance delta
Raised FY2026 outlook again: the Q3 analysis lists 13–14.5% sales growth and $47–$48 EPS, compared with prior-quarter analysis listing 11.5–13% daily organic sales growth and $45.50–$47.25 EPS. The growth measures are stated differently in the supplied analyses.
Key takeaways
- Q3 analysis reports 14.9% organic sales growth, 16.1% operating margin and EPS up over 22%.
- Both High-Touch Solutions and Endless Assortment were described as strong; data-center and contractor demand were cited as growth drivers.
- Management plans to integrate inventory-management technology; the analysis says it may initially weigh on margin before becoming neutral at scale.
Management priorities
- Integrate and scale the inventory-management technology acquisition.
- Use pricing actions and supplier rebates to protect price-cost neutrality amid inflation.
- Invest in marketing, delivery and pricing capabilities for Zoro and MonotaRO.
Follow GWW with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 4, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Sector Perform | Sector Perform | Maintain | Oct 14, 2026 |
| Barclays | Underweight | Underweight | Maintain | Sep 25, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 24, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Aug 6, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 5, 2026 |
| Stephens & Co. | Equal Weight | Overweight | Downgrade | Jul 14, 2026 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Jul 9, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Apr 21, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Feb 6, 2026 |
| Loop Capital | Hold | Hold | Maintain | Aug 4, 2025 |
| William Blair | Outperform | Market Perform | Upgrade | Mar 10, 2025 |
| Baird | Outperform | Neutral | Upgrade | Oct 16, 2024 |
| Erste Group | Hold | Buy | Downgrade | Jun 14, 2024 |
| UBS | Neutral | Neutral | Maintain | Mar 14, 2024 |
| Jefferies | Hold | Buy | Downgrade | Dec 20, 2023 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Nov 15, 2022 |
| Wells Fargo | Underweight | Underweight | Maintain | Apr 29, 2022 |
| Raymond James | Market Perform | Outperform | Downgrade | Aug 2, 2021 |
| Deutsche Bank | Hold | Hold | Maintain | May 3, 2021 |
| Gordon Haskett | Hold | Underperform | Upgrade | Jul 9, 2020 |
| Longbow Research | Buy | Neutral | Upgrade | Jun 2, 2020 |
| Buckingham Research | Neutral | Neutral | Maintain | Feb 7, 2020 |
| Buckingham | Neutral | Neutral | Maintain | Feb 7, 2020 |
| Gabelli & Co. | Buy | Hold | Upgrade | Feb 3, 2020 |
| BMO Capital | Market Perform | Market Perform | Maintain | Apr 23, 2019 |
| Macquarie | Outperform | Neutral | Upgrade | Jan 15, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Apr 23, 2018 |
| Stifel | Hold | Hold | Maintain | Apr 23, 2018 |
| Credit Suisse | Underperform | Underperform | Maintain | Jan 25, 2018 |
| Northcoast Research | Neutral | Neutral | Maintain | Jul 25, 2017 |
| Goldman Sachs | Sell | Sell | Maintain | Apr 18, 2016 |
| Sterne Agee CRT | Buy | Buy | Maintain | Mar 22, 2016 |
| KeyBanc | Equal Weight | Sector Weight | Maintain | Dec 18, 2015 |
| Susquehanna | Neutral | Neutral | Maintain | Jul 21, 2015 |
| FBR Capital | Market Perform | Market Perform | Maintain | Oct 17, 2014 |
| Citigroup | Hold | Hold | Maintain | Apr 15, 2014 |
| Wunderlich Securities | Buy | Buy | Maintain | Jan 22, 2014 |
| Wunderlich | Buy | Buy | Maintain | Jan 22, 2014 |
| BB&T Capital | Hold | Buy | Downgrade | Mar 13, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $1,489.39. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $1,172 | $1,279.47 | -21.3% | Sep 25, 2026 |
| Morgan Stanley | Analyst unavailable | $1,400 | $1,322.05 | -6.0% | Aug 24, 2026 |
| Barclays | Guy Hardwick | $1,185 | $1,297.45 | -20.4% | Aug 11, 2026 |
| D.A. Davidson | Chris Dankert | $1,260 | $1,270.92 | -15.4% | Aug 6, 2026 |
| RBC Capital | Analyst unavailable | $1,428 | $1,304.06 | -4.1% | Aug 5, 2026 |
| Oppenheimer | Analyst unavailable | $1,375 | $1,300.45 | -7.7% | Aug 5, 2026 |
| Robert W. Baird | Analyst unavailable | $1,400 | $1,300.45 | -6.0% | Aug 5, 2026 |
| RBC Capital | Analyst unavailable | $1,460 | $1,389.73 | -2.0% | Jul 16, 2026 |
| Redburn Partners | William Blunt | $1,280 | $1,375.76 | -14.1% | Jul 13, 2026 |
| Barclays | Guy Hardwick | $1,166 | $1,341.42 | -21.7% | Jun 23, 2026 |
| D.A. Davidson | Analyst unavailable | $1,250 | $1,313.92 | -16.1% | Jun 15, 2026 |
| Morgan Stanley | Christopher Snyder | $1,300 | $1,249.22 | -12.7% | May 27, 2026 |
| Barclays | Analyst unavailable | $1,171 | $1,226.09 | -21.4% | May 12, 2026 |
| Stephens | Tommy Moll | $1,355 | $1,233.71 | -9.0% | May 11, 2026 |
| RBC Capital | Analyst unavailable | $1,337 | $1,222.84 | -10.2% | May 8, 2026 |
| Robert W. Baird | Analyst unavailable | $1,365 | $1,227.37 | -8.4% | May 8, 2026 |
| Bernstein | Analyst unavailable | $1,125 | $1,163.1 | -24.5% | Apr 21, 2026 |
| Oppenheimer | Analyst unavailable | $1,300 | $1,168.92 | -12.7% | Feb 4, 2026 |
| RBC Capital | Analyst unavailable | $1,207 | $1,168.06 | -19.0% | Feb 4, 2026 |
| Robert W. Baird | David Manthey | $1,245 | $1,155 | -16.4% | Feb 4, 2026 |
| Barclays | Guy Hardwick | $1,044 | $1,155 | -29.9% | Feb 4, 2026 |
| Oppenheimer | Analyst unavailable | $1,250 | $1,049.97 | -16.1% | Jan 27, 2026 |
| Wolfe Research | Analyst unavailable | $1,081 | $959.07 | -27.4% | Dec 9, 2025 |
| Morgan Stanley | Christopher Snyder | $1,100 | $938.52 | -26.1% | Nov 25, 2025 |
| Barclays | Analyst unavailable | $963 | $958.82 | -35.3% | Oct 7, 2025 |
| Loop Capital Markets | Analyst unavailable | $950 | $938.27 | -36.2% | Aug 4, 2025 |
| RBC Capital | Analyst unavailable | $1,007 | $938.27 | -32.4% | Aug 4, 2025 |
| Stephens | Analyst unavailable | $1,200 | $938.27 | -19.4% | Aug 4, 2025 |
| Wolfe Research | Analyst unavailable | $966 | $973.41 | -35.1% | Apr 3, 2025 |
| Loop Capital Markets | Analyst unavailable | $1,100 | $985.06 | -26.1% | Mar 5, 2025 |
| Robert W. Baird | David Manthey | $1,230 | $1,085.57 | -17.4% | Oct 16, 2024 |
| Bank of America Securities | Sabrina Abrams | $925 | $1,033.24 | -37.9% | Oct 7, 2024 |
| CFRA | Jonathan Sakraida | $950 | $1,000.52 | -36.2% | Sep 13, 2024 |
| Morgan Stanley | Christopher Snyder | $990 | $938.48 | -33.5% | Sep 6, 2024 |
| Robert W. Baird | David Manthey | $975 | $939.12 | -34.5% | May 29, 2024 |
| Loop Capital Markets | Chris Dankert | $975 | $929.26 | -34.5% | Apr 29, 2024 |
| Morgan Stanley | Analyst unavailable | $537 | $680.95 | -63.9% | Feb 3, 2023 |
| Morgan Stanley | Analyst unavailable | $490 | $552.48 | -67.1% | Jan 6, 2023 |
| UBS | Analyst unavailable | $695 | $594.56 | -53.3% | Nov 29, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $448 | $549.6 | -69.9% | Aug 1, 2022 |
| Morgan Stanley | Analyst unavailable | $448 | $549.52 | -69.9% | Aug 1, 2022 |
| RBC Capital | Deane Dray | $422 | $538.12 | -71.7% | Aug 1, 2022 |
| Stephens | Analyst unavailable | $600 | $537.16 | -59.7% | Aug 1, 2022 |
| Morgan Stanley | Analyst unavailable | $421 | $457.4 | -71.7% | Jul 15, 2022 |
| Morgan Stanley | Analyst unavailable | $449 | $483.6 | -69.9% | May 31, 2022 |
| Morgan Stanley | Analyst unavailable | $474 | $511.29 | -68.2% | Apr 29, 2022 |
| RBC Capital | Analyst unavailable | $450 | $514 | -69.8% | Apr 29, 2022 |
| Wells Fargo | Analyst unavailable | $475 | $514.93 | -68.1% | Apr 29, 2022 |
Track every rating change on GWW the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationW.W. Grainger, Inc. stands as a significant global supplier of maintenance, repair, and operating (MRO) supplies and related services. Its market presence spans several international regions, including the United States, Japan, Canada, and the United Kingdom. The company structures its operations into two principal divisions: High-Touch Solutions N.A. and Endless Assortment. Grainger's extensive product offerings cover essential categories such as safety and security provisions, equipment for material handling and storage, plumbing and pump components, cleaning and facility upkeep items, and…
Historical context
All GWW earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| LTM LATAM Airlines Group S.A. | FY2026 Q3 · Calendar Q4 2026 | +25.2% | +9.5% | LATAM Q3 revenue grew as management held full-year guidance amid fuel costs |
| SWK Stanley Black & Decker, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +17.2% | Brand-led growth and raised guidance face cost and execution risks |
| AME AMETEK, Inc. | FY2026 Q3 · Calendar Q4 2026 | +4.7% | +2.8% | AMETEK raises FY2026 outlook after record Q3 and 35% order growth |
| ETN Eaton Corporation plc | FY2026 Q3 · Calendar Q4 2026 | +4.0% | +7.0% | Eaton raises 2026 outlook as electrical demand and backlog strengthen |
| TRI Thomson Reuters Corporation | FY2026 Q3 · Calendar Q4 2026 | -9.0% | -9.9% | Thomson Reuters lifts 2026 outlook as AI products expand |
Latest beats and misses
Who reports nextBeat on EPS
- IFFFY2026 Q3 · November 3, 2026+2.1% EPS-4.9% move
- JKHYFY2027 Q1 · November 3, 2026+10.1% EPS+10.8% move
- HL-PBFY2026 Q3 · November 3, 2026+54.0% EPS— move
- SUFY2026 Q3 · November 3, 2026+20.9% EPS-4.5% move
- AFGFY2026 Q3 · November 3, 2026+4.5% EPS+1.0% move
- WTRGFY2026 Q3 · November 3, 2026+13.7% EPS+2.5% move
Missed on EPS
- OHIFY2026 Q3 · November 3, 2026-42.5% EPS+3.5% move
- MOSFY2026 Q3 · November 3, 2026-1656.0% EPS+17.4% move
- OVVFY2026 Q3 · November 3, 2026-2.0% EPS-5.1% move
- BSACFY2026 Q3 · October 30, 2026-20.0% EPS-3.0% move
- TXFY2026 Q3 · November 3, 2026-24.9% EPS-0.0% move
- CHTFY2026 Q3 · November 4, 2026-55.7% EPS+0.9% move
Get the GWW recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-11-04T20:04:55.633640+00:00
- FN2 earnings calendar · 2026-11-04T01:23:13.345574+00:00
- Polygon adjusted daily market bars · 2026-11-04T21:30:47.254518+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-04T21:30:47.251628+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-04. For educational purposes only; not investment advice.